Annual Retained Earnings
-$53.39 M
-$7.79 M-17.10%
December 1, 2023
Summary
- As of February 8, 2025, DRMA annual retained earnings is -$53.39 million, with the most recent change of -$7.79 million (-17.10%) on December 1, 2023.
- During the last 3 years, DRMA annual retained earnings has fallen by -$25.31 million (-90.13%).
- DRMA annual retained earnings is now -114.90% below its all-time high of -$24.84 million, reached on December 31, 2019.
Performance
DRMA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$62.52 M
-$3.17 M-5.35%
September 1, 2024
Summary
- As of February 8, 2025, DRMA quarterly retained earnings is -$62.52 million, with the most recent change of -$3.17 million (-5.35%) on September 1, 2024.
- Over the past year, DRMA quarterly retained earnings has dropped by -$9.14 million (-17.11%).
- DRMA quarterly retained earnings is now -122.67% below its all-time high of -$28.08 million, reached on December 31, 2020.
Performance
DRMA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
DRMA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.1% | -17.1% |
| 3 y3 years | -90.1% | -26.2% |
| 5 y5 years | -114.9% | -26.2% |
DRMA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.4% | at low | -73.8% | at low |
| 5 y | 5-year | -114.9% | at low | -122.7% | at low |
| alltime | all time | -114.9% | at low | -122.7% | at low |
Dermata Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$62.52 M(+5.3%) |
| Jun 2024 | - | -$59.35 M(+5.0%) |
| Mar 2024 | - | -$56.52 M(+5.9%) |
| Dec 2023 | -$53.39 M(+17.1%) | -$53.39 M(+4.2%) |
| Sep 2023 | - | -$51.25 M(+3.5%) |
| Jun 2023 | - | -$49.53 M(+3.6%) |
| Mar 2023 | - | -$47.83 M(+4.9%) |
| Dec 2022 | -$45.59 M | -$45.59 M(+3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -$43.92 M(+5.8%) |
| Jun 2022 | - | -$41.50 M(+7.0%) |
| Mar 2022 | - | -$38.77 M(+7.7%) |
| Dec 2021 | -$35.98 M(+28.1%) | -$35.98 M(+7.6%) |
| Sep 2021 | - | -$33.43 M(+5.4%) |
| Jun 2021 | - | -$31.72 M(+4.4%) |
| Mar 2021 | - | -$30.38 M(+8.2%) |
| Dec 2020 | -$28.08 M(+13.0%) | -$28.08 M |
| Dec 2019 | -$24.84 M | - |
FAQ
- What is Dermata Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Dermata Therapeutics?
- What is Dermata Therapeutics annual retained earnings year-on-year change?
- What is Dermata Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Dermata Therapeutics?
- What is Dermata Therapeutics quarterly retained earnings year-on-year change?
What is Dermata Therapeutics annual retained earnings?
The current annual retained earnings of DRMA is -$53.39 M
What is the all time high annual retained earnings for Dermata Therapeutics?
Dermata Therapeutics all-time high annual retained earnings is -$24.84 M
What is Dermata Therapeutics annual retained earnings year-on-year change?
Over the past year, DRMA annual retained earnings has changed by -$7.79 M (-17.10%)
What is Dermata Therapeutics quarterly retained earnings?
The current quarterly retained earnings of DRMA is -$62.52 M
What is the all time high quarterly retained earnings for Dermata Therapeutics?
Dermata Therapeutics all-time high quarterly retained earnings is -$28.08 M
What is Dermata Therapeutics quarterly retained earnings year-on-year change?
Over the past year, DRMA quarterly retained earnings has changed by -$9.14 M (-17.11%)